EVOFEM BIOSCIENCES, INC.

Profile

Company Names

EVOFEM BIOSCIENCES, INC.

Addresses

7770 REGENTS ROAD, SUITE 113-6188, SAN DIEGO, CA 92122

7770 REGENTS ROAD, SUITE 113-618, SAN DIEGO, CA 92122

7770 REGENTS ROAD, SUITE 113-618, SAN DIEGO, CA 92122

12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA 92130

12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA 92130

Phone Numbers

(858) 550-1900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$85,551,925.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2025-06-26 
$925,000.00 
$925,000.00 
$0.00 
Equity 
10
2025-04-08 
$750,000.00 
$1,500,000.00 
$750,000.00 
Equity 
9
2024-08-09 
$500,000.00 
$500,000.00 
$0.00 
Equity 
8
2024-07-12 
$500,000.00 
$500,000.00 
$0.00 
Equity 
7
2023-09-27 
$2,884,615.00 
$2,884,615.00 
$0.00 
Debt 
6
2023-02-17 
$1,384,616.00 
$1,384,616.00 
$0.00 
Debt 
5
2022-12-20 
$2,307,693.00 
$2,307,693.00 
$0.00 
Equity, Debt 
4
2020-10-14 
$25,000,000.00 
$25,000,000.00 
$0.00 
Debt 
3
2020-04-24 
$15,000,000.00 
$25,000,000.00 
$10,000,000.00 
Debt 
2
2019-04-11 
$30,000,001.00 
$80,000,000.00 
$49,999,999.00 
Equity 
1
2019-02-08 
$6,300,000.00 
$12,500,000.00 
$6,200,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RUSSELL 
 
BARRANS 
EXECUTIVE OFFICER
KELLY 
 
CULLWELL 
EXECUTIVE OFFICER
KELLY 
 
CULWELL 
EXECUTIVE OFFICER
JUSTIN 
 
FILE 
EXECUTIVE OFFICER
JUSTIN 
FILE 
EXECUTIVE OFFICER
JUSTIN 
J. 
FILE 
EXECUTIVE OFFICER
ALEXANDER 
A. 
FITZPATRICK 
EXECUTIVE OFFICER
GILLIAN 
 
GREER 
DIRECTOR
KIM 
P. 
KAMDAR 
DIRECTOR
TONY 
 
O-BRIAN 
DIRECTOR
TONY 
 
O-BRIEN 
DIRECTOR
SAUNDRA 
 
PELLETIER 
EXECUTIVE OFFICER, DIRECTOR
LISA 
 
RARICK 
DIRECTOR
COLIN 
 
RUTHERFORD 
DIRECTOR
IVY 
 
ZHANG 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-26 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-04-08 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-07-12 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-08-09 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-09-27 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-02-17 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-12-20 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-10-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-04-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-04-11 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-02-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
JOSEPH GUNNAR + CO. LLC
JOSEPH GUNNAR + CO. LLC
NONE
NONE
WELLS FARGO SECURITIES, LLC
NONE
NONE
PIPER JAFFRAY + CO.
665